The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Check IPO price against current price. This is circling the toilet bowl until a discounted placing
company's focus is the open pit portion of 5-6 mt not the underground portion as well. amc's *** packet npv for open pit is $241m not counting capex, pm credits or the refiner's cut. company is spending £30k a month. rto funds lasted just under 2 years. recent raise covers next year's drilling. bod taken pay cuts.
Stockbox event starts in an hour. Link here https://t.co/6oEFZyb8J1
From the Telegram Q&A sounds like focus is just on converting the open pit to JORC and into production as the cheapest option. Question now is whether these assays are enough for a JORC or if they need to drill again next summer.
Stockbox live presentation and Q&A tomorrow at 1900. https://twitter.com/StockBoxMedia/status/1732098157742358875?t=Kt_I9sxv5jCpq1tUrc-V9w&s=19
Live Q&A with CEO in the Hive Telegram Group https://twitter.com/TheHiveTeams/status/1731702530592084069?t=yG95jYnMbVCGklRu2o_kFA&s=19
Early bird -- they put up AMC Consultant's report. Page 11 shows the open pit base case with an NPV of $241m. That's without the underground piece. https://www.eaststarplc.com/presentations